Regular physical exercise promotes fitness and reduces cardiovascular risk factors, thereby contributing to maintenance of physical health, reduction of cardiovascular mortality, and improved life expectancy. There is a growing body of evidence, both from animal work and from human epidemiological and longitudinal intervention studies, that regular physical exercise also impacts directly on the central nervous system, mediating structural brain integrity and improving cognitive functioning. Modern neuroimaging approaches, in particular magnetic resonance imaging (MRI) based techniques, provide a powerful means to non-invasively study the effects of physical exercise on human brain structure and function in vivo. Positron emission tomography (PET) is another interesting technique, as it allows for quantification of neuroreceptor binding status of dedicated ligands in athletes, thereby, unravelling the central neurochemistry of exercise. Employing these techniques in exercise sciences will allow for determining central mechanisms of body-brain interactions, both, in health and disease states. It is expected that this may propagate individualized exercise training regimens for disease prevention and, ultimately, adapted applications for prevention and slowing down disease progression in neurodegenerative conditions. At current, however, these imaging techniques are largely based on inter-subject averaging and their impact for personalized medicine with the goal of promoting preventative and personalized healthcare remains to be determined.
SHIFT WORK AND BREAST CANCER
Richter K Clinic for Psychiatry and Psychotherapy, Clinic Nuernberg & Faculty for social work, GSO University Nuernberg, Germany Shift work increases the risk for breast cancer. The International Agency for Research on Cancer (IARC) has classified shift work as probably carcinogenic to humans (Group II A Carcinoma). This classification as probably carcinogenic is based on the fact that there is only limited evidence in humans but sufficient evidence from studies with laboratory animals. IARC is an institution of WHO. Shift work is included in the risk classification that categorises it as being at the same level as harming affects by UV radiation and acrylamides (ERREN). Poor light exposure during the night, disruptions of the sleep-wake-rhythm and the concomitant interruption of melatonin production are altogether likely to contribute to the development of breast cancer. Fluctuating melatonin levels modulate sex hormones synthesis and their consequent levels in the blood. This in turn increases the risk of hormone-induced diseases including breast carcinoma. Several international studies demonstrate an increased presence of breast cancer in nurses working predominantly in the night. Therefore, it is recommended to offer them the opportunity for regular preventive medical check-ups, since they belong to a risk group predisposed to breast cancer. Chronotype (early versus late sleepers) is the most important protector for adapting to shift work. After working in the morning shift, early sleepers sleep better and longer. In contrast, late sleepers better and longer after working in the night shift. This fact should be taken into consideration by employers when scheduling the employees either for morning or night shift according to individual chronotypes. This is a secure way how to prevent the employees against several pathologies.
Further studies to investigate, whether shift work promotes the occurrence of breast cancer in women with a positive family history are essential to be carried out. Should shift work turn out to represent a risk for breast cancer particularly increased in women with a positive family history, this will have a direct influence on the career choice of this patient cohort. Consequently, these individuals should be counselled in a way to persuade them to choose a career not related to shift work. In this process, the counselling activity could be triggered by health insurances. There is growing evidence that our next-future medical approach will consists of personalized medicine -based on pharmacogenomics, proteomics, metabolomics, physiomics. This approach developed out of the realization that patients diagnosed with the same disease often respond differently to drugs. Furthermore, proper "clever" individualized treatment is particularly difficult to find in disease early phases where the presence of biomarkers is still poor. Innovative tools are necessary to assist practitioners in making adequate therapeutic choices according to each patient in order to optimize the benefit-to-risk ratio of drugs. Recently, the treatment tailoring upon individual genetic profile has been proposed. However, nature is more complex and we now know that we have to focus on genes functions and interactions and gene products rather than on genes themselves. Even so the interplay between genes and environmental influences remains elusive. In addition, system biology is still at its infancy, being extremely expensive and not affordable everywhere.
AYURVEDA, THE PARADIGM FOR PERSONALIZED MEDICINE
We propose an integrated approach based on a traditional medicine view to transform our understanding of complex diseases and best prevent them. Ayurveda-India's traditional system of medicine-emphasize the importance of preventing before treating illness through body-mind awareness and lifestyle. It looks beyond the purely structural view by considering life as a complex interrelationship of several forces. It has a time-honored philosophical and experiential basis, being founded on Apta or knowledge from previous experience, Pratyaksha or data derived from observation, Anumana or inference due to evidence of constant Abnormalities in the variability of blood pressure and heart rate-commonly referred to as vascular variability disorders or VVDs-are impossible to detect in a conventional office visit, yet can raise the relative cardiovascular disease risk (gauged by the occurrence of a morbid event over the next 6 years) from 9% to 100%. These risks, silent to the subject involved and the conventional care-provider, notably the risk of circadian hyper-amplitude tension or CHAT can usually be reduced if not reversed by chronobiological self-help, with or without pharmacological approaches [1] . The proportion of omega-6 in tissue highly unsaturated fatty acids or HUFA is a surrogate endpoint in successful primary prevention of coronary heart disease or CHD. The% omega-6 HUFA helps predicting the likely risk of a fatal event. This surrogate endpoint gives each individual a clear indication of personal risk and also an indication of success in personal compliance with well-focused nutritional advice. People with more than half of their HUFA as omega-6 (Ω6S) are at a greater risk of death from CHD than those with less than half [2] . The two factors are at the basis of a current tentative mindbody approach to preventive personalized medicine that aims at (1) targeting variability, (2) enhancing performance, and (3) detecting pre-metabolic syndrome (pMS). Basing on a great number of research works conducted by the Therapeutic Dentistry Department's staff, it was concluded that a clinical outcome of caries prevention appears to be influenced by a wide range and combination of individual parameters: level of metabolic processes in humans, human cardiovascular, endocrine and digestive systems state, pH value, oral fluid pH, enamel and dentin metabolic processes activity, dental pulp response, periodontal condition and other aspects. Consequently, each patient needs to be treated individually according to his/her individual dental health. It raises the pertinent question: What exactly should be personalized and how? Answering that with respect to the scientific research, we came to the following conclusion: the preventive measures and treatment strategies must be clearly defined in preventive medicine.
THE EFFECT OF THE SUPPLEMENTATION OMEGA 3 FATTY ACIDS TO LIPIDS AND ANTHROPO-METRIC PARAMETERS IN THE OBESE YOUNG VOLUNTEERS
A complete diagnostic examination is of top priority for effectiveness of further preventive measures. Our longstanding research activities have given us an option of developing, adapting to the practice, and implementing a minimized spectrum of research methods making it possible to detect individual cariogenic components. That is why we concluded that currently applied diagnostic methods are not personalized: they should be standard and unified for all patients examined. The individual cariogenic factors revealed the course of examination making personalized prevention and treatments possible. Therefore, it is strategically important that the diagnostic phase will be unified and the prevention and treatment phase will be personalized. 
